Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Launched by UNIVERSITY OF CALIFORNIA, IRVINE · Jan 16, 2013
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is a pilot study that aims to use a special imaging technique called multiphoton microscopy to look at skin lesions without needing to take a sample or do any surgery. Researchers want to understand more about both pigmented (like moles) and non-pigmented skin lesions by examining their features in a way that is safe and non-invasive. This could help doctors better characterize these skin conditions and improve patient care.
The study is open to all genders and age groups, as long as participants can understand and follow the instructions given to them. However, pregnant women are not eligible to join the trial. If you decide to participate, you can expect to undergo a simple imaging procedure that does not involve any cutting or needles. This study is currently recruiting participants, so if you're interested and meet the criteria, you could contribute to important research in skin health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or Female all age groups
- • Ability to understand and carry out subject instructions
- Exclusion Criteria:
- • Pregnant women
About University Of California, Irvine
The University of California, Irvine (UCI) is a leading research institution renowned for its commitment to advancing health and medical knowledge through innovative clinical trials. With a robust infrastructure for clinical research, UCI fosters interdisciplinary collaboration among its esteemed faculty and researchers, aiming to translate scientific discoveries into effective therapeutic solutions. The university prioritizes ethical standards and participant safety while addressing critical healthcare challenges across various fields, including cancer, neurology, and public health. UCI's dedication to excellence in research and education positions it as a pivotal contributor to the advancement of clinical science and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Irvine, California, United States
Patients applied
Trial Officials
Kristen Kelly, MD
Principal Investigator
Beckman Laser Institute, UCI
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials